Amazing AntiViral and AntiTumor Treatment only from wood grown Shiitake Mushroom extract AHCC

Could Japanese mushrooms kill the HPV virus that causes cervical cancer?

• Extract found in shiitake mushrooms may help prevent HPV-related cancers
• HPV is a contagious infection that affects skin, cervix, mouth and throat 
• Shiitake mushrooms contain chemical AHCC which may boost immunity
• 5/10 women given extract were successfully treated for cervical cancer

HPV is spread via sexual contact and causes cervical cancer in women as well as cancer of the throat, anus and penis.

Shiitake mushrooms, which have been used medicinally in their native East Asia for centuries,

They contain a unique chemical called active hexose correlated compound (AHCC), which is a mixture of amino acids, polysaccharides and minerals.

Currently, there is no effective medicine or supplement to treat HPV, which is associated with more than 99 percent of cervical cancer cases.

In the new study, 10 women with the HPV virus were given an extract of the mushroom, once a day for six months.

'We were able to determine at least three months of treatment is necessary but some need to extend that to six months.

'Since AHCC is a nutritional supplement with no side effects and other immune modulating benefits, we will be planning on using six months of treatment in our phase two clinical study to have consistent study treatment plan.'

Previous research has shown AHCC boosts the immune system by increasing the number of cells which help the body fight off infections and block tumour growth.

Professor Smith presented her results at an International Conference of the Society for Integrative Oncology in Texas.

It is understood that while the results were seen in women, AHCC will have the same result on men. 

It may also be capable of treating genital warts in men.

Earlier this year, she reported that in mice, AHCC led to the eradication of HPV within 90 days.

 https://www.sciencedaily.com/releases/2014/10/141028122424.htm

 Human and preclinical studies have shown that AHCC increases the number and/or activity of Natural Killer (NK) cells, dendritic cells and cytokines, which help the body fight off infections and block tumor growth.

 https://patents.justia.com/patent/9931316

Antiviral activity from medicinal mushrooms and their active constituents

Sep 14, 2015

Compounds having unique antiviral properties found in mushroom mycelium and their analogs are extracted, concentrated, isolated or manufactured to create compositions useful in preventing the spread and proliferation of various viruses afflicting animals, particularly viruses harming humans, pigs, birds, bats and bees. Such compounds and compositions can be used individually or in combination with known medicines or natural products to improve health.

 Additionally, a 2015 ‘white paper’ by Jeffery S. Chilton, Redefining Medicinal Mushrooms: A new scientific screening program for active compounds states that if mycelium is grown on rice, and not wood, that “Without the natural precursors, basidiomycete mycelium in sterile culture produces few of the important secondary metabolites.” Thus these three experts, skilled in the art, and greatly influential, are unanimous in discrediting any significant activity of non-hot water mycelial extracts, especially when mycelium is grown on grains such as rice. Thus they teach away from the specifics of this invention.

 culture of the mycelia of the basidiomycete, shiitake (Lentinula edodes).

The effect of the antiviral and antibacterial components within the aforementioned mushroom species and their relatives may be the decisive factor that improves survivability from infection in many animals including humans, dogs, cats, horses, cows, pigs, birds, fish, insects (including bees) and other wild and domesticated animals. Moreover, these mushroom extracts, and natural or synthetic versions of the compounds contained in such extracts, can enhance and be combined with a wide range of conventional anticancer therapies, including chemotherapies using herceptin, tamoxifen, taxol, interferon alpha, as well as vaccines, gene therapies, including incorporating nanobots, radiological, immunological, sonic, photonic, electrical, cold shock, electromagnetic, and microbiomic and other cancer therapies.

Lowering the cancer-causing effects of viruses and bacteria are a consequence of and are derived from the antiviral, antibacterial and other medicinal effects of polypore mushroom mycelia in particular, and the mycelia from other medicinal mushrooms in general, as described in U.S. Pat. No. 8,765,138, issued Jul. 1, 2014 by the inventor. By employing extracts and the derivative active ingredients from these antiviral and antibacterial fungi, improvement in survivability of patients can be significantly realized.

https://www.ncbi.nlm.nih.gov/pubmed/28008808

  The antitumor effect of the mycelial extracts from all 3 fungal species was ascertained in vivo in rats with implanted kidney cancer. Dystrophic changes in tumor cells and tumor necrosis (up to 90%) were noted. In vitro cytotoxicity studies of the A549 human lung adenocarcinoma cell line and HEp-2 human laryngeal epidermoid carcinoma cells showed that the extracts from the G. lucidum fruiting bodies and from the L. edodes vegetative mycelium were the most effective.